|
SMAD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71800000003941E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.01460000000587E-05 |
| Normal-vs-Stage2 |
5.979600E-04 |
| Normal-vs-Stage3 |
1.18049999997538E-07 |
| Normal-vs-Stage4 |
2.52380000009822E-07 |
| Stage1-vs-Stage2 |
3.997400E-01 |
| Stage1-vs-Stage3 |
2.377900E-02 |
| Stage1-vs-Stage4 |
2.052400E-02 |
| Stage2-vs-Stage3 |
4.611800E-01 |
| Stage2-vs-Stage4 |
3.502200E-01 |
| Stage3-vs-Stage4 |
7.473200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79349999962497E-07 |
| Normal-vs-AfricanAmerican |
4.359500E-03 |
| Normal-vs-Asian |
1.326630E-01 |
| Caucasian-vs-AfricanAmerican |
3.834400E-01 |
| Caucasian-vs-Asian |
7.775400E-01 |
| AfricanAmerican-vs-Asian |
9.502400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20660000005424E-06 |
| Normal-vs-Female |
1.39890000028231E-07 |
| Male-vs-Female |
5.658600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.436140E-02 |
| Normal-vs-Age(41-60Yrs) |
1.572950E-04 |
| Normal-vs-Age(61-80Yrs) |
1.03349999669433E-08 |
| Normal-vs-Age(81-100Yrs) |
1.350590E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.997200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.491200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.853580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.978400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.163800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.618800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.782000E-01 |
| Normal-vs-Grade 2 |
3.977200E-04 |
| Normal-vs-Grade 3 |
4.8323000045869E-09 |
| Normal-vs-Grade 4 |
1.10200004677097E-09 |
| Grade 1-vs-Grade 2 |
1.293750E-01 |
| Grade 1-vs-Grade 3 |
4.753500E-02 |
| Grade 1-vs-Grade 4 |
2.212400E-02 |
| Grade 2-vs-Grade 3 |
1.004030E-02 |
| Grade 2-vs-Grade 4 |
1.025690E-04 |
| Grade 3-vs-Grade 4 |
7.483600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.9632499999922E-05 |
| Normal-vs-ccB subtype |
2.606300E-04 |
| ccA subtype-vs-ccB subtype |
4.109600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71400000000111E-05 |
| Normal-vs-N1 |
4.76209999988875E-07 |
| N0-vs-N1 |
9.237400E-03 |
|
|
